*Aedes aegypti* is the principal vector of arboviral diseases, such as dengue, hemorrhagic dengue, Zika, chikungunya, and yellow fevers. The incidence of dengue fever has grown remarkably in recent decades worldwide ([@B29]). In the American continent, it has increased from 16.4 cases per 100,000 residents in 1980 to 218.3 per 100,000 in the period 2000-2010 and it continues to seriously affect this region. The number of reported cases across South-East Asia, Western Pacific and even in North America and European countries has continued to increase as well, which reveals the threat of outbreaks of dengue fever in these regions ([@B18], [@B27]). In Brazil, from January to December, 2015, 1,649,008 cases were notified (almost three times the number reported for the same period in 2014), including 15,693 severe cases and 886 deaths ([@B18], [@B27]). With regard to 2016 epidemiological update, 224,064 cases of dengue have already been reported in Brazil until the end of February, with 102 severe cases and 52 deaths ([@B18]), therefore warranting urgent measures for its control.

Initially limited to the African continent, Zika fever has expanded its geographical range since 2007. To date, autochthonous Zika virus transmission has been confirmed in a total of 59 countries and territories, with prevalence in those of Latin America and the Caribbean - 31 countries and territories in 2016 ([@B30]). This is twice the number that has been reported for this region up to December, 2015, as having locally acquired infection by Zika ([@B16]). According to the World Health Organization, 3 to 4 million infections by Zika virus are estimated in the Americas for 2016, in which 0.4 to 1.3 million cases are anticipated in Brazil, where Zika fever was first confirmed in 2015 ([@B4], [@B30]). Of greatest concern is a potential established association between Zika virus infection and a growing incidence of microcephaly cases in newborns and neurological disorders, as Guillain-Barré syndrome (GBS). According to Brazilian health authorities, the number of reported cases of congenital microcephaly and/or other central nervous system malformations with laboratory-confirmed Zika virus congenital infection has increased since 2015 ([@B19]). From October 2015 to March 2016, 907 of such cases were confirmed nationwide, while 4,268 cases are still under investigation ([@B19]). Among the 198 child deaths which occurred during pregnancy or after birth, 46 of these were linked to congenital virus infection ([@B19]). In this context, de [@B5] recently provided evidence of human transplacental transmission of Zika virus and also demonstrated its fetal neurotropism. As for the incidence of GBS, 12 countries and territories in the Americas have reported a steep increase in GBS notified cases and/or Zika virus infection among GBS registered cases ([@B30]). Based on the foregoing data, Zika fever, as a fast-emerging, pandemic-prone disease, was considered in the beginning of 2016 a Public Health Emergency of International Concern ([@B28]).

Originally restricted to Africa and the Indian subcontinent, chikungunya has recently been reported from Europe and the Americas ([@B3], [@B26]). In the American continent, cases of this fever, whose symptoms may persist for months, have been detected in 33 countries and territories since December 2013. In Brazil, from January to December 2015, a total of 22,813 cases, including three deaths, was informed ([@B17]). Therefore, chikungunya, as well as dengue and Zika fevers, has emerged as a serious public health problem.

Despite research advances from the pharmaceutical industry, developing dengue, Zika and chikungunya vaccines has proven a complex task and these vector-borne diseases remain a global public health challenge. Meanwhile, controlling the incidence of dengue, Zika and chikungunya fevers has largely depended on effectively fighting its main primary vector, *Ae. aegypti*, a mosquito highly adapted to urban environments. So, strategies must be strengthened, particularly in the Americas, aiming at its elimination. Reducing the vector population with synthetic insecticides to target its larval stage in breeding sites remains the main strategy for successful vector management ([@B6]). Nonetheless, a major obstacle to this approach has been the continued use of conventional insecticides, such as organophosphates and carbamates - a practice that leads to development of resistant species ([@B12]). In addition, the deleterious effects of synthetic insecticides on the environment and non-target organisms have stimulated the search for alternative eco-friendly larvicidal agents, such as plant-derived secondary metabolites ([@B10], [@B9], [@B11], [@B22], [@B1], [@B2]). As part of our ongoing screening program for plants of the Cerrado and Pantanal - two outstanding biomes in Midwest Brazil - as potential sources of agents against *Ae. aegypti* ([@B8]), a total of 36 crude extracts from different anatomical parts (aerial parts, leaves, stems, roots, fruits and/or seeds) of 27 species belonging to 18 different families were assessed for their larvicidal activity in the present work. Of the extracts evaluated, only that from seeds of *Guarea kunthiana* (Meliaceae) proved active, being therefore selected for a bioassay-guided fractionation. Herein, we report the isolation and structure elucidation of its bioactive constituent.

MATERIALS AND METHODS
=====================

^1^H and ^13^C NMR spectra were obtained in CDCl~3~ (Cambridge Isotope Laboratories, Andover, USA) on a Bruker DPX-300 spectrometer (Karlhue, Germany), operating at 300.13 MHz (^1^H)/75.47 MHz (^13^C). EIMS data were acquired at 70 eV on a Shimadzu (Tokyo, Japan) QP5000 DI-50 instrument. Pre-coated silica gel GF254 chromatoplates (Merck, Darmstadt, Germany) were used for analytical thin-layer chromatographic procedures. Silica gel 60 (230-400 mesh, Merck) and silica gel 60 RP-18 (230-400 mesh, Merck) were used for column chromatography.

*Plant material* - The plants investigated ([Table I](#t1){ref-type="table"}) were collected from Cerrado and Pantanal areas in Mato Grosso do Sul, Brazil, from August 2009 to August 2012 and identified by Dr Arnildo Pott (Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil). Voucher specimens are deposited at the CGMS Herbarium of the Universidade Federal de Mato Grosso do Sul.

TABLE IPlants evaluated and activity of their ethanol extracts against third-instar *Aedes aegypti* larvaeSpecies (Family)Voucher numberSite of collection/BiomePlant partLC~50~ (mg/mL)*Anona cornifolia* A. St.-Hil. (Annonaceae)WG234Campo Grande/CerradoAerial partsI*Vernonia ferruginea* Less. (Asteraceae)WG223Campo Grande/CerradoStemsI*V. ferruginea* Less. (Asteraceae)Campo Grande/CerradoLeavesI*Tabebuia aurea* (Silva Manso) Benth. & Hook. f. ex S. Moore (Bignoniaceae)WG073Corumbá/PantanalLeavesI*T. aurea* (Silva Manso) Benth. & Hook. f. ex S. Moore (Bignoniaceae)Corumbá/PantanalStemsI*T. avellanedae* var. paulensis (Bignoniaceae)WG150Corumbá/PantanalStemsI*T. impetiginosa* (Mart. ex DC.) Standl. (Bignoniaceae)WG177Aquidauana/CerradoLeavesI*T. ochracea* (Cham.) Standl. (Bignoniaceae)WG224Campo Grande/CerradoLeavesI*Costus spiralis* (Jacq.) Roscoe (Costaceae)WG215Campo Grande/CerradoAerial partsI*C. spiralis* (Jacq.) Roscoe (Costaceae)Campo Grande/CerradoRootsI*Doliocarpus dentatus* (Aubl.) Standl. (Dilleniaceae)WG248Dois Irmãos do Buriti/CerradoLeavesI*Erythroxylum campestre* A. St.-Hil. (Erythroxylaceae)WG226Campo Grande/CerradoLeavesI*Cassytha filiformis* L. (Lauraceae)WG072Campo Grande/CerradoLeavesI*Mezilaurus crassiramea (Meisn.) Taub. ex Mez* (Lauraceae)WG256Corumbá/PantanalFruitsI*Ocotea suaveolens* (Meisn) Benth. & Hook. f. ex Hieron. (Lauraceae)WG076Corumbá/PantanalFruitsI*Strychnos pseudoquina* A. St.-Hil. (Loganiaceae)WG108Campo Grande/CerradoFruitsI*S. pseudoquina* A. St.-Hil. (Loganiaceae)Campo Grande/CerradoLeavesI*S. pseudoquina* A. St.-Hil. (Loganiaceae)Campo Grande/CerradoStemsI*Guazuma ulmifolia* Lam. (Malvaceae)WG17Campo Grande/CerradoLeavesI*Miconia albicans* (Sw.) Steud. (Melastomataceae)WG181Campo Grande/CerradoStemsI*Guarea kunthiana* A. Juss. (Meliaceae)WG239Bodoquena/CerradoFruits (peel and pulp)I*G. kunthiana* A. Juss. (Meliaceae)Bodoquena/CerradoSeeds169.93*Trichilia pallida* Sw. (Meliaceae)WG232Corumbá/PantanalFruitsI*Hyeronima alchorneoides* Allemão (Phyllanthaceae)WG213Campo Grande/CerradoLeavesI*Roupala montana* Aubl. (Proteaceae)WG202Aquidauana/CerradoLeavesI*R. montana* Aubl. (Proteaceae)Aquidauana/CerradoStemsI*Palicourea marcgravii* A. St.-Hil. (Rubiaceae)WG218Campo Grande/CerradoLeavesI*P. marcgravii* A. St.-Hil. (Rubiaceae)Campo Grande/CerradoStemsI*Pogonopus tubulosus* (A. Rich.) K. Schum. (Rubiaceae)WG230Aquidauana/CerradoFruitsI*Psychotria carthagenensis* Jacq. (Rubiaceae)WG221Campo Grande/CerradoStemsI*Chrysophyllum marginatum* (Hook. & Arn.) Radlk. (Sapotaceae)WG219Campo Grande/CerradoStemsI*Matayba guianensis* Aubl. (Sapindaceae)WG093Aquidauana/CerradoLeavesI*Siparuna guianensis* Aubl. (Siparunaceae)WG220Campo Grande/CerradoFruitsI*Cestrum virgatum Ruiz & Pav.* (Solanaceae)WG231Aquidauana/CerradoStemsI*Solanum lycocarpum* A. St.-Hil. (Solanaceae)WG227Campo Grande/CerradoFruitsI*S. lycocarpum* A. St.-Hil. (Solanaceae)Campo Grande/CerradoLeavesI[^1]

*Preparation of extracts* - Air-dried and powdered plant material (aerial parts, leaves, stems, roots, fruits and/or seeds, at least 500 g each) was extracted with ethanol (4 x 2L) at room temperature. After concentration *in vacuo*, the residue obtained from each extract was stored at -18ºC until biological screening was performed.

*Bioassay-guided fractionation of seeds of G. kunthiana* - Fruits of *G. kunthiana* were collected in August 2012 and their seeds (1,000 g) were separated from the pulp and peel (3,000 g). The seeds were extracted with ethanol (4 x 4 L) for seven days and filtered. After concentration under reduced pressure, the bioactive ethanol extract was subsequently partitioned between MeOH-H~2~O (9:1) and hexane. Water was added to the hydromethanolic phase to yield a MeOH-H~2~O (1:1) mixture, which was partitioned with EtOAc. The hexane (9.0 g), EtOAc (14.0 g), and hydromethanolic (2.0 g) phases were tested against *Ae. aegypti* larvae, and the larvicidal activity was found to reside in the EtOAc solubles (LC~50~ = 105.70 mg/mL). An aliquot of this bioactive phase (11.0 g) was then chromatographed on an RP-18 silica gel (350.0 g) column, using step gradient elution with MeOH-H~2~O (4:6, 6:4, 8:2), MeOH, and CHCl~3~ to give five fractions (F1-F5) of 500 mL each. Testing for larvicidal activity showed fraction F3 (2.0 g), containing two major components, to be bioactive (LC~50~ = 15.20 mg/mL). An aliquot of this fraction (800.0 mg) was further subjected to column chromatography on silica gel (30.0 g) using CHCl~3~ (750 mL), CHCl~3~-MeOH (9.7:0.3, 750 mL), CHCl~3~-MeOH (9.5:0.5, 750 mL), CHCl~3~-MeOH (9.3:0.7, 750 mL), and CHCl~3~-MeOH (9:1, 750 mL), yielding protolimonoids **1** (510.0 mg, major compound, eluted with CHCl~3~-MeOH 9.5:0.5) and **2** (210.6 mg, eluted with CHCl~3~-MeOH 9.3:0.7), both of which were tested against *Ae. aegypti* larvae. Only compound **1** proved bioactive (LC~50~ = 14.44 mg/mL). Purity of protolimonoids **1** and **2** was established on the basis of their ^1^H and ^13^C NMR spectra and by chromatographic techniques.

*Melianodiol (* ***1*** *)* - colorless amorphous powder; EIMS (70 eV), *m/z* (rel. ab.): 488 (M^+.^, 4), 470 (8) \[M - H~2~O\], 455 (25) \[M - ^.^CH~3~\], 412 (17) \[470 - CH~3~COCH~3~\], 397 (59) \[455 - CH~3~COCH~3~/ 412 - ^.^CH~3~\], 379 (34) \[ 397 - H~2~O\], 365 (92) \[397 - CH~3~OH\], 297 (67) \[379 - C~5~H~6~O\], 59 (100) \[ C~3~H~7~O^+^\]; ^1^H NMR (CDCl~3~, 300 MHz): δ 2.76 (1H, td, *J* = 14.4, 5.2 Hz, 2-H); 5.25 (1H, brs, 7-H); 0.83 (3H, s, 18-H); 1.01 (3H, s, 19-H); 5.32 (1H, brs, 21-H); 4.38 (1H, m, 23-H); 3.15 (1H, brs, 24-H); 1.26 (3H, s, 26-H); 1.28 (3H, s, 27-H); 1.03 (3H, s, 28-H); 1.12 (3H, s, 29-H); 1.03 (3H, s, 30-H); ^13^C-NMR (CDCl~3~, 75 MHz): δ 38.5 (C-1); 35.0 (C-2); 216.9 (C-3); 47.8 (C-4); 52.3/52.4 (C-5); 24.3 (C-6); 118.0 (C-7); 145.6 (C-8); 48.3/48.8 (C-9); 35.1 (C-10); 17.6 (C-11); 30.1/31.4 (C-12); 43.5/43.6 (C-13); 50.7 (C-14); 34.2 (C-15); 27.2 (C-16); 45.3 (C-17); 21.5 (C-18); 12.7 (C-19); 45.2/46.3 (C-20); 96.7/102.2 (C-21); 30.2 (C-22); 78.7 (C-23); 74.8/75.8 (C-24); 73.2 (C-25); 26.5 (C-26); 26.7 (C-27); 24.5 (C-28); 23.2 (C-29); 27.4 (C-30). ^1^H and ^13^C NMR, and mass spectra of melianodiol are shown in Supplementary figures .

*Meliantriol* ***(2)*** - colorless amorphous powder; EIMS (70 eV), *m/z* (rel. ab.): 490 (M^+.^, 15), 475 (19) \[M - ^.^CH~3~\], 457 (40) \[475 - H~2~O\], 439 (61) \[457 -- H~2~O\], 399 (39) \[457 - CH~3~COCH~3~\], 381 (40) \[399 - H~2~O\], 367 (100) \[399 - CH~3~OH\], 349 (20) \[367- H~2~O\], 281 (39) \[ 381 - C~5~H~8~O~2~\]; ^1^H NMR (CDCl~3~, 300 MHz): δ 3.22 (1H, dd, *J* = 11.0, 3.5 Hz, 3-H); 5.21 (1H, brs, 7-H); 0.82 (3H, s, 18-H); 0.72 (3H, s, 19-H); 5.24 (1H, brs, 21-H); 4.34 (1H, m, 23-H); 3.14 (1H, brs, 24-H); 1.26 (3H, s, 26-H); 1.24 (3H, s, 27-H); 0.84 (3H, s, 28-H); 0.94 (3H, s, 29-H); 0.96 (3H, s, 30-H); ^13^C-NMR (CDCl~3~, 75 MHz): δ 37.2 (C-1); 27.5 (C-2); 79.1 (C-3); 39.0 (C-4); 50.7 (C-5); 24.0 (C-6); 118.2 (C-7); 145.4 (C-8); 48.8 (C-9); 34.9 (C-10); 17.5 (C-11); 31.6 (C-12); 43.7 (C-13); 50.7 (C-14); 34.2 (C-15); 27.3 (C-16); 50.7 (C-17); 23.2 (C-18); 13.1 (C-19); 45.3/46.5 (C-20); 97.1/102.3 (C-21); 34.2 (C-22); 77.4/78.7 (C-23); 75.1 (C-24); 73.4 (C-25); 26.5 (C-26); 26.7 (C-27); 27.5 (C-28); 14.7 (C-29); 27.3 (C-30). ^1^H and ^13^C NMR, and mass spectra of meliantriol are shown in Supplementary figures.

*Larvicidal activity assay against Ae. aegypti* - The bioassays were performed according to World Health Organization protocols ([@B31]) with slight modifications ([@B8]). Mosquito eggs (Rockefeller strain) were obtained from a colony maintained at our laboratory. The adult colony was provided with 10% saccharose solution and adult female mosquitoes were blood-fed on Swiss mice for egg production. The eggs were then hatched by immersion in distilled water for 1 h, followed by incubation in the dark at 27 (± 2) ºC and 70 (± 5) % relative humidity. Larvae were fed on fish food and, upon reaching the third instar, the larvae were used in the bioassays. Stock solutions at 1,000, 500, 250, 125, 62.5 and 31.25 mg/mL were prepared from each plant extract, as well as from the partition phases and fractions originating from *G. kunthiana* seeds. To this end, the samples were dissolved in distilled water containing 0.5% dimethylsulfoxide (DMSO). For F3 (the bioactive fraction), serial diluting yielded test solutions of concentrations as low as 15 mg/mL. Compounds **1** and **2** were each initially tested at 100, 80, 60, 40 and 20 mg/mL. Compound **1** (the bioactive protolimonoid) was subsequently tested at concentrations as low as 15 mg/mL to allow calculating its LC~50~ value. The purity of the isolated compounds tested was ≥ 95%. Ten third-instar larvae were placed in a beaker containing 5 mL of test sample. For each concentration, 40 larvae were exposed (four replicates of 10 larvae each). A set of controls was also run, using 0.5% DMSO in distilled water in four replicates. Each assay was repeated three times at different days and showed no significant variation. Larval mortality was recorded 24 h after treatment at 27 (± 2) ºC, during which no food was given to the larvae. Larvae were considered dead when they did not respond to stimuli (gentle poking with a pipette). All the experiments were carried out at 27 (± 2) ºC and 70 (± 5) % relative humidity.

Considering the mortality of the larvae at the experimental concentrations, the LC~50~ and LC~90~ values (µg/mL), slope and Chi-square value were calculated using the Probit analysis on IBM SPSS Statistics 22.0. Comparison among samples in relation to the LC~50~ and LC~90~ values was performed using the 95% confidence interval from LCs ratio ([@B25]).

Mosquito eggs (Rockefeller strain) were obtained from a colony maintained at our laboratory (permit 469/2012 from the Animal Ethics Committee of the Universidade Federal de Mato Grosso do Sul), according to the Conselho Nacional de Controle de Experimentação Animal - CONCEA/Ministério da Ciência, Tecnologia e Inovação-MCTI (http://www.mct.gov.br/index.php/content/view/310553.html). The authors declare no conflicts of interest.

RESULTS
=======

Of the 36 crude extracts tested, only that prepared from *G. kunthiana* seeds proved active against *Ae. aegypti* larvae (LC~50~ = 169.93 μg/mL). No larval deaths occurred with any of the other extracts, not even that prepared from *G. kunthiana* fruit peel and pulp, which had LC~50~ values higher than 1,000 μg/mL ([Table I](#t1){ref-type="table"}).

Based on these results, a bioassay-guided investigation of the ethanol extract of *G. kunthiana* seeds was conducted, and the larvicidal activity was found to reside in the EtOAc phase - with LC~50~ and LC~90~ values of 105.70 and 408.91 mg/mL, respectively ([Table II](#t2){ref-type="table"}), obtained by extract partitioning, since both hexane and hydromethanolic phases exhibited LC~50~ values higher than 1,000 µg/mL.

TABLE IIToxicity of extract, fractions and isolated compound against 3rd instars of *Aedes aegypti* after 24 h exposureTreatmentLC~50~ (μg/mL) (95% FL)LC~90~ (μg/mL) (95% FL)Slope (±SE)*x* ^2^*Guarea kunthiana* EtOH extract169.93a (141.62-203.41)496.11a (389.56-692.46)2.75±0.298.58EtOAc phase105.70b (83.85-130.30)408.91b (310.56-598.17)2.18±0.2424.88Bioactive fraction15.20c (14.59-15.62)18.25c (17.80-18.91)16.11±2.0312.69Melianodiol (**1**)14.44d (13.53-15.01)17.54d (17.10-18.15)15.20±2.2714.37Meliantriol (**2**)\> 100\> 100\--[^2]

This phase was then subjected to column chromatography procedures and the resulting bioactive fraction (LC~50~ = 15.20 mg/mL, [Table II](#t2){ref-type="table"}), containing two principal components, was further separated, leading to the isolation and characterisation of the known protolimonoids melianodiol (**1**, major compound) and meliantriol (**2**) ([Figure](#f01){ref-type="fig"}). Their structures were established on the basis of ^1^H and ^13^C NMR spectroscopic techniques supported by mass spectra, as well as by comparison with previously reported data, and authentic samples ([@B20], [@B13], [@B14]).

Structures of protolimonoids melianodiol (1) and meliantriol (2).

After evaluation for toxicity against *Ae. aegypti* larvae, only compound **1** proved biologically active, with LC~50~ and LC~90~ values of 14.44 and 17.54 mg/mL, respectively, as depicted in [Table II](#t2){ref-type="table"}, while **2** had an LC~50~ value above 100 mg/mL.

All samples showed dose/response curve (slope) different from 0 degree (p \< 0.001) and *p* values greater than 0.15 on chi-square test (p = 0.995; p = 0.303; p = 1.000; p = 1.000, respectively). All samples were also significantly different with respect to the LC~50~ and LC~90~ values (based on ratio test; p \< 0.05), and also presented decreasing LC values from crude extract to the isolated bioactive compound (melianodiol, **1**).

DISCUSSION
==========

In the present study, the protolimonoid melianodiol (**1**) was isolated as the larvicidal constituent of the bioactive ethyl acetate phase obtained after partitioning of the ethanol extract of the seeds of *G. kunthiana*. Meliantriol (**2**), which was also obtained from the bioactive fraction, was nevertheless devoid of any larval toxicity, even at the highest concentration tested. These results indicate that the larvicidal activity of **1** stems from the presence of the carbonyl moiety at C-3 in the 21,23-epoxy-21,24,25-trihydroxy-tirucall-7-ene-type skeleton, since its corresponding reduced derivative **2**, which differs from **1** only for bearing a hydroxyl function at that same carbon, was found to be inactive.

Meliaceae, the family to which the genus *Guarea* belongs, is a rich source of secondary metabolites, including limonoids and protolimonoids ([@B24], [@B23]). In a previous investigation of *G. kunthiana*, we isolated **1** and **2** from the fruits, and di- and sesquiterpenes, poliprenol-12, and α- and d-tocopherols from the leaves ([@B7], [@B14]. The fruits also yielded the limonoids humilinolide E, 2-hydroxy-6-deoxyswietenine, swietenin acetate and methyl angolensate ([@B15], none of which were found to be present in our *G. kunthiana* bioactive fraction from which melianodiol (**1**) was obtained, despite the fact that limonoids are known for their biological, and particularly insecticidal, properties ([@B23]. They were shown to be present, however, in a more polar, otherwise inactive fraction resulting from chromatographic separation of the bioactive EtOAc phase. To our knowledge, only the protolimonoid nilocitin has hitherto been reported to exhibit significant growth disruption and morphological deformities against *Ae. aegypti* larvae and pupae ([@B21], and the present investigation is therefore the first to isolate melianodiol by conduction a bioassay-guided study of plant constituents active against *Ae. aegypti* larvae.

The foregoing results revealed melianodiol to be a potential candidate for the development of an ecologically sound alternative to environmentally hazardous synthetic insecticides currently employed to control *Ae. aegypti* larvae in areas where dengue, Zika and chikungunya fevers are of concern. Also, melianodiol was isolated from seeds, a feature that encourages the conservation and sustainable use of *G. kunthiana* as a source of this bioactive compound. The findings warrant investigating other Meliaceous species, as well as members of the Simaroubaceae and Rutaceae, from which protolimonoids have also been obtained, for their potential towards the development of new biocontrol agents against *Ae. aegypti* larvae.
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[^1]: I: inactive (LC~50~ value \> 1000 mg/mL)

[^2]: FL = fiducial limits; SE = standard error. Values within a column followed by different letters are significantly different (p \< 0.05) based on the ratio test of 95% fiducial limits.
